February 27, 2026 · Form 4 insider transaction
Frank Steven bought 1,285 shares of BioCryst Pharmaceuticals, Inc. at $8.75 per share, a transaction worth $11.2K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Shares of Common Stock issued to the reporting person in lieu of 100% of the quarterly cash Board Member retainer of $11,250.